Buell Jennifer 4
4 · MiNK Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Buell Jennifer
Chief Executive Officer
Transactions
- Award
Common Stock
2026-01-02$11.12/sh+31,474$349,991→ 67,966 total - Award
Stock Option (Right to Buy)
2026-01-02+50,000→ 50,000 totalExercise: $11.12Exp: 2036-01-02→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Reflects the executive's 2025 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on February 2, 2026.
- [F2]$11.12 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 2, 2026, the stock issuance date.
- [F3]The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the date of grant, with the remainder vesting in eight equal quarterly installments thereafter.